Back to Search Start Over

Assessing the inter-observer variability of Computer-Aided Nodule Assessment and Risk Yield (CANARY) to characterize lung adenocarcinomas.

Authors :
Nakajima EC
Frankland MP
Johnson TF
Antic SL
Chen H
Chen SC
Karwoski RA
Walker R
Landman BA
Clay RD
Bartholmai BJ
Rajagopalan S
Peikert T
Massion PP
Maldonado F
Source :
PloS one [PLoS One] 2018 Jun 01; Vol. 13 (6), pp. e0198118. Date of Electronic Publication: 2018 Jun 01 (Print Publication: 2018).
Publication Year :
2018

Abstract

Lung adenocarcinoma (ADC), the most common lung cancer type, is recognized increasingly as a disease spectrum. To guide individualized patient care, a non-invasive means of distinguishing indolent from aggressive ADC subtypes is needed urgently. Computer-Aided Nodule Assessment and Risk Yield (CANARY) is a novel computed tomography (CT) tool that characterizes early ADCs by detecting nine distinct CT voxel classes, representing a spectrum of lepidic to invasive growth, within an ADC. CANARY characterization has been shown to correlate with ADC histology and patient outcomes. This study evaluated the inter-observer variability of CANARY analysis. Three novice observers segmented and analyzed independently 95 biopsy-confirmed lung ADCs from Vanderbilt University Medical Center/Nashville Veterans Administration Tennessee Valley Healthcare system (VUMC/TVHS) and the Mayo Clinic (Mayo). Inter-observer variability was measured using intra-class correlation coefficient (ICC). The average ICC for all CANARY classes was 0.828 (95% CI 0.76, 0.895) for the VUMC/TVHS cohort, and 0.852 (95% CI 0.804, 0.901) for the Mayo cohort. The most invasive voxel classes had the highest ICC values. To determine whether nodule size influenced inter-observer variability, an additional cohort of 49 sub-centimeter nodules from Mayo were also segmented by three observers, with similar ICC results. Our study demonstrates that CANARY ADC classification between novice CANARY users has an acceptably low degree of variability, and supports the further development of CANARY for clinical application.<br />Competing Interests: FM, TP, BJB, and SR report intellectual property and royalties received from Imbio, LLC (Minneapolis, MN), which licenses CANARY. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The remaining authors have nothing to disclose.

Details

Language :
English
ISSN :
1932-6203
Volume :
13
Issue :
6
Database :
MEDLINE
Journal :
PloS one
Publication Type :
Academic Journal
Accession number :
29856852
Full Text :
https://doi.org/10.1371/journal.pone.0198118